289 listed pharmaceutical companies rank among the top five with market value exceeding 100 billion yuan

[China Pharmaceutical network industry trends] as of May 24, 289 listed pharmaceutical companies were listed According to the relevant data of tonghuashun, there are five listed pharmaceutical companies with a total market value of more than 100 billion yuan, namely, Hengrui Pharmaceutical Co., Ltd with a total market value of 266.524 billion yuan, Kangmei Pharmaceutical Co., Ltd with a total market value of 134.902 billion yuan, Yunnan Baiyao Pharmaceutical Co., Ltd with a total market value of 120.917 billion yuan, Fosun Pharmaceutical Co., Ltd with a total market value of 106.579 billion yuan and Wuxi Wuxi Pharmaceutical Co., Ltd with a total market value of 101 In addition, there are 108 pharmaceutical companies with a total market value of more than 10 billion yuan, such as Shanghai Laishi 97.204 billion yuan, aer eye 79.385 billion yuan, Zhifei biology 78.384 billion yuan, meinian health 78.169 billion yuan, etc (the following data as of May 24) the total market value of Hengrui pharmaceutical is 266.524 billion yuan The number of days of listing: 6428 days, Hengrui pharmaceutical was founded in 1970 and listed on the Shanghai Stock Exchange in 2000 Hengrui pharmaceutical is the supplier of anti-tumor drugs, surgical drugs and contrast agents in China, and also the leading unit of national anti-tumor technology innovation industry university research alliance It has established national targeted drug engineering technology research center and postdoctoral research workstation, and has won many national major special projects From the market value of less than 100 billion yuan in 2015 to becoming a domestic pharmaceutical enterprise with a market value of more than 200 billion yuan in 2017, what's the logic behind "giant" Hengrui pharmaceutical? The answer is R & D and sales In 2018, Hengrui pharmaceutical will usher in a period of intensive harvest Three varieties, 19K, pyrrolidine and shr-1210, are expected to be approved for listing by the end of the year In addition, Hengrui pharmaceutical also actively expands the retail market It is reported that in the past three years, the retail market of Hengrui medicine has maintained a rapid growth of more than 30% The total market value of Kangmei pharmaceutical is 134902 million yuan The number of listing days: 6276 days, Kangmei pharmaceutical was founded in 1997 and listed on the Shanghai Stock Exchange in 2001 Kangmei pharmaceutical has laid out the whole industry chain of traditional Chinese medicine on the Internet in China With the production of herbal pieces as the core, it has comprehensively built a large listed enterprise of "wisdom +" big health industry in the whole industry chain of traditional Chinese medicine with the system of "big health + big platform + big data + big service" Since the distribution of Chinese Herbal Pieces in 2002, Kangmei pharmaceutical industry has been extending to the upstream and downstream of the industry to build the whole industrial chain layout of Chinese herbal medicine At present, a complete layout and industrial system of large health industry has been formed Analysts of Guosen Securities said that Kangmei pharmaceutical industry is the leader of the decoction piece industry, and constantly promotes the upgrading of the whole industry chain of traditional Chinese medicine, builds innovative business models and creates new growth points, with expected sustained high growth in performance The total market value of Yunnan Baiyao is 120.917 billion yuan The number of days to be listed is 8927 days Yunnan Baiyao was founded by Mr Qu Huanzhang, a famous folk doctor in Yunnan Province, in 1902 The company was listed on the Shenzhen Stock Exchange in 1993 and became a listed company of a shares in Yunnan Province It is reported that the management of Yunnan Baiyao involves chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal medicines, biological products, etc The operating revenue of Yunnan Baiyao 2018q1 is about 6.34 billion yuan, with a year-on-year increase of about 7.3% and a year-on-year decrease of about 7% Among them, the operating revenue of the parent company is about 1.38 billion yuan, with a year-on-year growth rate of about 10.9% and a year-on-year growth rate of about 10 percentage points In addition to the reason of high year-on-year base of revenue, relevant agencies believe that the pressure of the company's pharmaceutical sector is still large, and it is expected that the revenue growth will accelerate after the completion of product price increase and channel sorting The total market value of Fosun Pharmaceutical is 106.579 billion yuan The listing days are 7231 days Fosun Pharmaceutical was founded in 1994 and listed on Shanghai Stock Exchange in August 1998 It is a leading listed company in China's pharmaceutical industry Fosun Pharmaceutical takes the promotion of human health as its mission, and its business covers the whole medical and health industry chain, mainly including drug manufacturing and R & D, medical services, medical devices and medical diagnosis, pharmaceutical distribution and retail On May 25, near 11:23 p.m., Fosun Pharmaceutical changed and its share price rose 5.03% to a new high in January As of 11:23, the stock was at 46.38 yuan / share, with 2334400 transactions, a turnover rate of 1.22%, an amplitude of 3.95%, and a volume ratio of 2.76 In addition, in the past year, the stock has not been up or down The total market value of Wuxi apptec is 101.698 billion yuan, listing days: 17 days, Wuxi apptec was founded in 2000 and listed on the Shanghai Stock Exchange on May 8, 2018 As a research-oriented and customer-centric company, Wuxi apptec provides a series of laboratory research and development, research and production services to global pharmaceutical companies, biotechnology companies and medical device companies, covering the whole process from drug discovery to market I learned that in the morning of May 24, Wuxi Wuxi Pharmaceutical Co., Ltd once again increased its price limit to 97.60 yuan, with a total market value of 101.7 billion yuan In addition to today's trading board, Wuxi apptec has been trading up for 13 consecutive days (including 44% increase on the first day) As the issuing price of Wuxi apptec is 21.6 yuan, it means that each signing has made a profit of 76000 yuan, and it continues to brush the record of making new shares in the new year.